Short-course hormonal therapy and the risk of death from prostate cancer in men with intermediate-risk prostate cancer undergoing high-dose radiation therapy

被引：0
作者：
Keane, Florence K.
Chen, Ming-Hui
Zhang, Danjie
Moran, Brian Joseph
Braccioforte, Michelle H.
D'Amico, Anthony Victor
机构：
[1] Brigham & Womens Hosp, Harvard Radiat Oncol Program, Boston, MA 02115 USA
[2] Univ Connecticut, Storrs, CT USA
[3] Prostate Canc Fdn Chicago, Westmont, IL USA
[4] Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 07期
关键词：
D O I：
10.1200/jco.2015.33.7_suppl.27
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
27
引用
收藏
页数：1
相关论文
共 50 条
[21]   Comorbidity and androgen deprivation therapy use in men undergoing high-dose radiation for unfavorable-risk prostate cancer [J].
Dyer, Michael A. ;
Chen, Ming-Hui ;
Braccioforte, Michelle H. ;
Moran, Brian J. ;
D'Amico, Anthony V. .
JOURNAL OF RADIATION ONCOLOGY, 2016, 5 (03) :293-300
[22]   Comorbidity and androgen deprivation therapy use in men undergoing high-dose radiation for unfavorable intermediate- and high-risk prostate cancer. [J].
Dyer, Michael A. ;
Chen, Ming-Hui ;
Braccioforte, Michelle H. ;
Moran, Brian Joseph ;
D'Amico, Anthony V. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
[23]   Race and the Risk of Death Following High-Dose Radiation Therapy in Men Treated With or Without Androgen Suppression Therapy for Favorable-Risk Prostate Cancer [J].
Kovtun, K. ;
Chen, M. H. ;
Braccioforte, M. H. ;
Moran, B. J. ;
D'Amico, A. V. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02) :E402-E402
[24]   Management of high-risk prostate cancer: Radiation therapy and hormonal therapy [J].
Nomiya, Takuma ;
Tsuji, Hiroshi ;
Toyama, Shingo ;
Maruyama, Katsuya ;
Nemoto, Kenji ;
Tsujii, Hirohiko ;
Kamada, Tadashi .
CANCER TREATMENT REVIEWS, 2013, 39 (08) :872-878
[25]   Re: Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men with Favorable Intermediate-risk Prostate Cancer [J].
Gandaglia, Giorgio ;
Briganti, Alberto ;
Montorsi, Francesco .
EUROPEAN UROLOGY, 2016, 69 (02) :370-370
[26]   Re: Risk Group and Death from Prostate Cancer: Implications for Active Surveillance in Men with Favorable Intermediate-Risk Prostate Cancer [J].
Taneja, Samir S. .
JOURNAL OF UROLOGY, 2016, 196 (02) :412-413
[27]   Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer [J].
Ju, Andrew W. ;
Wang, Hongkun ;
Oermann, Eric K. ;
Sherer, Benjamin A. ;
Uhm, Sunghae ;
Chen, Viola J. ;
Pendharkar, Arjun V. ;
Hanscom, Heather N. ;
Kim, Joy S. ;
Lei, Siyuan ;
Suy, Simeng ;
Lynch, John H. ;
Dritschilo, Anatoly ;
Collins, Sean P. .
RADIATION ONCOLOGY, 2013, 8
[28]   Enzalutamide With Radiation Therapy for Intermediate-Risk Prostate Cancer: A Phase 2 Study [J].
Kaplan, Irving ;
Bubley, Glenn J. ;
Bhatt, Rupal S. ;
Taplin, Mary-Ellen ;
Dowling, Shanna ;
Mahoney, Kathleen ;
Werner, E. ;
Nguyen, Paul .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (05) :1416-1422
[29]   Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer [J].
Andrew W Ju ;
Hongkun Wang ;
Eric K Oermann ;
Benjamin A Sherer ;
Sunghae Uhm ;
Viola J Chen ;
Arjun V Pendharkar ;
Heather N Hanscom ;
Joy S Kim ;
Siyuan Lei ;
Simeng Suy ;
John H Lynch ;
Anatoly Dritschilo ;
Sean P Collins .
Radiation Oncology, 8
[30]   Combined hypofractionated radiation and hormone therapy for the treatment of intermediate-risk prostate cancer [J].
Yassa, Michael ;
Fortin, Bernard ;
Fortin, Marie-Andree ;
Lambert, Carole ;
Nguyen, Thu Van ;
Bahary, Jean-Paul .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (01) :58-63
12345